# Donepezil Attenuate Postoperative Cognitive Dysfunction

> **NCT02927522** · PHASE3 · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 550 (estimated)

## Conditions studied

- Osteoarthritis
- Femoral Head Necrosis
- Rheumatoid Arthritis

## Interventions

- **DRUG:** Donepezil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02927522
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-01
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2020-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02927522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02927522, "Donepezil Attenuate Postoperative Cognitive Dysfunction". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02927522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*